Topic 1: Molecular Foundations

Reimagining the fundamentals – "Coming back to the blackboard"

A return to basic physiology and biochemistry is key to address the unique challenges in Fontan circulation. Developing mechanistic approaches to comprehend altered core biological processes and revealing links between small molecule analytes on biochemical, transcriptomic, and genomic basis.

Hypothesis: Basic physiology and biochemistry is key to address unique Fontan challenges
Primary aim: Developing mechanistic approaches to comprehend altered core biological processes
Secondary aim: Revealing links on biochemical, transcriptomic and genomic basis
Explore Molecular Foundations

Topic 2: The Fontan radar

Harnessing the power of advanced Biomarkers and Omics

Omics technologies represent a medical revolution, key to unraveling the complex origins and interconnections of Fontan-related comorbidities. Exploring the full potential of existing biomarkers for improved diagnostics, risk stratification, and outcome prediction.

Hypothesis: Omics technologies are key to unraveling complex origins of Fontan-related comorbidities
Primary aim: Exploring full potential of existing biomarkers in Fontan and cardiology literature
Secondary aim: Developing accurate prognosis through strategic biomarker employment
Discover Biomarker Research

Topic 3: Cardiac Metabolism

Metabolism: a major factor determining outcomes in Fontan?

Metabolic and regulatory processes, including energy metabolism, oxidative stress, inflammation, immunity, and endothelial function are determining Fontan outcomes. Integrating hemodynamic and metabolic evaluations for a comprehensive understanding.

Hypothesis: Metabolic processes are determining Fontan outcomes
Primary aim: Integrating hemodynamic and metabolic evaluations
Secondary aim: Creating a comprehensive picture of Fontan pathophysiology
Learn About Metabolism Studies

Topic 4: Targeted metabolic Therapies

Pioneering development of Fontan targeted metabolic therapies

Expanding treatment options to live a full life with half a heart. Our consortium advances clinical trials focused on metabolic interventions for selected Fontan patient subgroups.

Hypothesis: Advancing metabolic intervention clinical trials
Primary aim: Comprehensive approach from traditional medical therapies to a targeted metabolic therapy
Secondary aim: Improving quality of life for Fontan patients
Explore Therapeutic Development